Aloha Medicinals Sustainability Profile
Aloha Medicinals, a leading name in the biotechnology sector, is headquartered in the United States, with significant operations across North America and beyond. Founded in 2000, the company has established itself as a pioneer in the cultivation and production of medicinal mushrooms, focusing on high-quality mycelium and fruiting body extracts. Aloha Medicinals is renowned for its unique, scientifically-backed products that cater to the health and wellness market, including dietary supplements and functional foods. Their commitment to sustainability and innovation has positioned them as a trusted supplier in the industry, achieving notable milestones such as partnerships with major health brands. With a strong emphasis on research and development, Aloha Medicinals continues to lead the way in harnessing the therapeutic potential of mushrooms, setting a benchmark for quality and efficacy in the market.
DitchCarbon Score
How does Aloha Medicinals's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Education Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Aloha Medicinals's score of 23 is lower than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Aloha Medicinals's reported carbon emissions
Aloha Medicinals, headquartered in the US, currently does not have available carbon emissions data for the most recent year. As a current subsidiary of Aloha Medicinals, Inc., the company has not reported specific emissions figures, including Scope 1, 2, or 3 emissions, nor has it set documented reduction targets or climate pledges. Despite the absence of specific emissions data, Aloha Medicinals is part of a broader industry context that increasingly prioritises sustainability and climate commitments. The company may be expected to align with industry standards and initiatives aimed at reducing carbon footprints, although no specific initiatives or targets have been disclosed at this time. As the company continues to develop its climate strategy, stakeholders will be looking for future commitments and data disclosures that reflect its environmental impact and sustainability goals.
How Carbon Intensive is Aloha Medicinals's Industry?
How Carbon Intensive is Aloha Medicinals's Location?
Aloha Medicinals's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Aloha Medicinals has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Nature'S Elements Holding Corporation
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.